Statement of the Problem: Opportunistic infections such as Pseudomonas aeruginosa, colonized from the oral cavity, are common in candidates of bone marrow transplantation. Therefore, it is important to prescribe appropriate antibiotics for this group of debilitated patients.
Purpose: In this study, we aimed to investigate the antibiotic resistance to Pseudomonas aeruginosa encountered in candidates of bone marrow transplantation referred to Imam Reza Clinic, Namazi Hospital, and Amir Hospital, Shiraz, Iran.
Materials and Method: This cross-sectional study was performed on 30 patients with leukemia and lymphoma. To identify Pseudomonas species, saliva samples were collected and cultured in a blood agar medium. Considering the present therapies, we examined the antibiotic sensitivity of Penicillin, Oxacillin, Gentamicin, Tetracycline, Cefepime, Ciprofloxacin, Imipenem, Ceftazidime, Cefotaxime, Erythromycin, Trimethoprim, Sulfamethoxazole, and Vancomycin. Statistical analysis was performed using chi-square test (χ2) and SPSS software. P value < 0.05 was considered significant.
Results: In 10 patients out of 30 for whom Pseudomonas aeruginosa was found positive (33.33%), all cultures were resistant to Penicillin and Oxacillin (100%), followed by Trimethoprim and Sulfamethoxazole (80%). The best performance was seen by Vancomycin (20%). No correlation was found in terms of age, gender, and type of disease (lymphoma or leukemia) for antibiotic resistance (p> 0.05).
Conclusion: It seems that Penicillin, Oxacillin, Tetracycline, Sulfamethoxazole have significant resistance to Pseudomonas aeruginosa. Further research on Gentamicin, Ceftazidime, Ciprofloxacin, and especially Vancomycin is recommended for effective antibiotic prescriptions against Pseudomonas aeruginosa. |
- Qin TJ, Mi YC, Feng SZ, Li DP, Wei JL, Yang DL, et al. Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia. Natl Med J China. 2007; 87: 1389–1393.
- Abdollahi A, Hakimi F, Doomanlou M, Azadegan A. Microbial and antibiotic susceptibility profile among clinical samples of patients with acute leukemia. Int J Hematol Stem Cell Res. 2016; 10: 61–69.
- Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood. 2012; 119: 34–43.
- Delavigne K, Bérard E, Bertoli S, Corre J, Duchayne E, Demur C, et al. Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy. Haematologica. 2014; 99: 474–480.
- Saini L, Rostein C, Atenafu EG, Brandwein JM. Ambulatory consolidation chemotherapy for acute myeloid leukemia with antibacterial prophylaxis is associated with frequent bacteremia and the emergence of fluoroquinolone resistant E. Coli. BMC Infect Dis. 2013; 13: 1-7.
- Aota K, Kani K, Yamanoi T, Momota Y, Ninomiya M, Yumoto H, et al. Management of tooth extraction in a patient with ELANE gene mutation-induced cyclic neutropenia: A case report. Medicine (Baltimore). 2019; 98:
- Wingard JR, Hsu J, Hiemenz JW. Hematopoietic stem cell transplantation: An overview of infection risks and epidemiology. Infect Dis Clin North Am. 2010; 24: 257-272.
- Balasubramanian D, Schneper L, Kumari H, Mathee K. A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res. 2013; 41: 1-20.
- Lefebvre A, Bertrand X, Quantin C, Vanhems P, Lucet JC, Nuemi G, et al. Association between Pseudomonas aeruginosa positive water samples and healthcare-associated cases: nine-year study at one university hospital. J Hosp Infect. 2017; 96: 238–243.
- Anaissie EJ, Penzak SR, Dignani MC. The hospital water supply as a source of nosocomial infections: A plea for action. Arch Intern Med. 2002; 162: 1483–1492.
- Zaatout N. Presence of non-oral bacteria in the oral cavity. Arch Microbiol. 2021; 203: 2747-2760.
- Viksne R, Racenis K, Broks R, Balode AO, Kise L, Kroica J. In Vitro Assessment of Biofilm Production, Antibacterial Resistance of Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp. Obtained from Tonsillar Crypts of Healthy Adults. Microorganisms. 2023; 11: 258.
- Riera E, Cabot G, Mulet X, García-Castillo M, Del Campo R, Juan C, et al. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. J Antimicrob Chemother. 2011; 66: 2022-2027.
- Neumann S, Krause SW, Maschmeyer G, Schiel X, Von Lilienfeld-Toal M. Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2013; 92: 433-442.
- Jarlier V, Diaz Högberg L, Heuer OE, Campos J, Eckmanns T, Giske CG, et al. Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016. Euro Surveill. 2019; 24: 1800538.
- Agarwal M, Larson EL. Risk of drug resistance in repeat gram-negative infections among patients with multiple hospitalizations. J Crit Care. 2018; 43: 260–264.
- Perez P, Patiño J, Estacio M, Pino J, Manzi E, Medina D. Bacteremia in pediatric patients with hematopoietic stem cell transplantation. Hematol Transfus Cell Ther. 2020; 42: 5–11.
- Ramos MMB, Gaetti-Jardim EC, Gaetti-Jardim E. Resistance to tetracycline and β-lactams and distribution of resistance markers in enteric microorganisms and pseudomonads isolated from the oral cavity. J Appl Oral Sci. 2009; 17: 13-18.
- Mechergui A, Achour W, Mathlouthi S, Hassen A Ben. Prevalence of infectious multi-drug resistant bacteria isolated from immunocompromised patients in Tunisia. Afr Health Sci. 2019; 19: 2021–2025.
- Subramaniam N, Muthukrishnan A. Oral mucositis and microbial colonization in oral cancer patients undergoing radiotherapy and chemotherapy: A prospective analysis in a tertiary care dental hospital. J Invest Clin Dent. 2019; 10: e12454.
- Forbes BA, Saham DF, Weissfeld AS. Baily and Scott s Diagnostic Microbiology. 12th ed. Mosby: Inc., an anffilliate of Elsevier, Inc.; 2007. p.103.
- Giske CG, Monnet DL, Cars O, Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008; 52: 813-821.
- Diene SM, Rolain JM. Carbapenemase genes and genetic platforms in Gram-negative bacilli: Enterobacteriaceae, Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2014; 20: 831-838.
- Willyard C. The drug-resistant bacteria that pose the greatest health threats. Nature. 2017; 543: 15.
- Zahed M, Bahador M, Asl MH, Lavaee F, Azad A, Bahador A. Oro-dental health of patients with chronic hepatic failure. Int J Organ Transplant Med. 2020; 11: 115.
- Zahed M, Ranjbar MA, Azad A. Oral Health-Related Quality of Life in Chronic Liver Failure Patients Measured by OHIP-14 and GOHAI. Biomed Res Int. 2020; 2020:
- El-Beeli M, Al-Farsi Y, Balkhair A, Al-Muharrmi Z, Al-Jabri M, Al-Adawi S. Estimation of Prevalence of Hospital-Acquired Blood Infections among Patients Admitted at a Tertiary Hospital in Oman over a Period of Five Years: A Cross-Sectional Study. Interdiscip Perspect Infect Dis. 2023; 2023: 5853779.
- Satlin MJ, Walsh TJ. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients. Transpl Infect. 2017; 19: e12762.
- Oliveira AL, de Souza M, Carvalho-Dias VMH, Ruiz MA, Silla L, Tanaka PY, et al. Epidemiology of bacteremia and factors associated with multi-drug-resistant gram -negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2007; 39: 775–781.
- Kraiem AG, Zorgani A, Elahmer O, El Salabi AA, Ghennghesh KS. Carbapenem-resistant gram-negative bacilli in Tripoli, Libya. Am J Infect Control. 2016; 44: 1192-1194.
- Schiavano GF, Carloni E, Andreoni F, Magi S, Chironna M, Brandi G, et al. Prevalence and antibiotic resistance of Pseudomonas aeruginosa in water samples in central Italy and molecular characterization of oprD in imipenem resistant isolates. Galdiero M, editor. PLoS One. 2017; 12: e0189172.
- Rodríguez-Martínez JM, Poirel L, Nordmann P. Extended-spectrum cephalosporinases in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2009; 53: 1766–1771.
- Bassetti M, De Waele JJ, Eggimann P, Garnacho-Montero J, Kahlmeter G, Menichetti F, et al. Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med. 2015; 41: 776-795.
- Johansen HK, Moskowitz SM, Ciofu O, Pressler T, Høiby N. Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J Cyst Fibros. 2008; 7: 391–397.
- Meunier A, Nerich V, Fagnoni-Legat C, Richard M, Mazel D, Adotevi O, Bertrand X, Hocquet D. Enhanced emergence of antibiotic-resistant pathogenic bacteria after in vitro induction with cancer chemotherapy drugs. J Antimicrob Chemother. 2019; 74: 1572-1577.
- Sookhakian A, Zahed M, Pakshir H, Ajami S. Salivary IGF-1 and Alkaline Phosphatase-Based Modeling for Skeletal Maturity Prediction in Orthodontic Patients. Biomed Res Int. 2022; 21: 2390865.
- Webb K, Cámara M, Zain NM, Halliday N, Bruce KD, Nash EF, Whitehouse JL, Knox A, Forrester D, Smyth AR, Williams P. Novel detection of specific bacterial quorum sensing molecules in saliva: Potential non-invasive biomarkers for pulmonary Pseudomonas aeruginosa in cystic fibrosis. J Cyst Fibros. 2022; 21: 626-629.
|
